PubMed

Cost-effectiveness of aliskiren in type 2 diabetes, hypertension, and albuminuria.

Delea TE, Sofrygin O, Palmer JL, Lau H, Munk VC, Sung J, Charney A, Parving HH, Sullivan SD.

J Am Soc Nephrol. 2009 Oct;20(10):2205-13. Epub 2009 Sep 17.PMID: 19762496 [PubMed - indexed for MEDLINE]Related articles

Retrospective study of the association between transfusion frequency and potential complications of iron overload in patients with myelodysplastic syndrome and other acquired hematopoietic disorders.

Delea TE, Hagiwara M, Phatak PD.

Curr Med Res Opin. 2009 Jan;25(1):139-47.PMID: 19210147 [PubMed - indexed for MEDLINE]Related articles

Healthcare use and costs in patients with chronic bronchitis initiating maintenance therapy with fluticasone/salmeterol vs other inhaled maintenance therapies.

Delea TE, Hagiwara M, Dalal AA, Stanford RH, Blanchette CM.

Curr Med Res Opin. 2009 Jan;25(1):1-13.PMID: 19210134 [PubMed - indexed for MEDLINE]Related articles

Association between adherence with fixed dose combination fluticasone propionate/salmeterol on asthma outcomes and costs*.

Delea TE, Stanford RH, Hagiwara M, Stempel DA.

Curr Med Res Opin. 2008 Dec;24(12):3435-42.PMID: 19032125 [PubMed - indexed for MEDLINE]Related articles

Effects of fluticasone propionate/salmeterol combination on asthma-related health care resource utilization and costs and adherence in children and adults with asthma.

Delea TE, Hagiwara M, Stanford RH, Stempel DA.

Clin Ther. 2008 Mar;30(3):560-71.PMID: 18405796 [PubMed - indexed for MEDLINE]Related articles

Outcomes, utilization, and costs among thalassemia and sickle cell disease patients receiving deferoxamine therapy in the United States.

Delea TE, Hagiwara M, Thomas SK, Baladi JF, Phatak PD, Coates TD.

Am J Hematol. 2008 Apr;83(4):263-70.PMID: 17924547 [PubMed - indexed for MEDLINE]Related articles

Consequences and costs of noncompliance with iron chelation therapy in patients with transfusion-dependent thalassemia: a literature review.

Delea TE, Edelsberg J, Sofrygin O, Thomas SK, Baladi JF, Phatak PD, Coates TD.

Transfusion. 2007 Oct;47(10):1919-29. Review.PMID: 17880620 [PubMed - indexed for MEDLINE]Related articles

Cost-effectiveness of letrozole versus tamoxifen as initial adjuvant therapy in postmenopausal women with hormone-receptor positive early breast cancer from a Canadian perspective.

Delea TE, El-Ouagari K, Karnon J, Sofrygin O.

Breast Cancer Res Treat. 2008 Apr;108(3):375-87. Epub 2007 Jul 26.PMID: 17653859 [PubMed - indexed for MEDLINE]Related articles

Cost-effectiveness of letrozole versus tamoxifen as initial adjuvant therapy in hormone receptor-positive postmenopausal women with early-stage breast cancer.

Delea TE, Karnon J, Sofrygin O, Thomas SK, Papo NL, Barghout V.

Clin Breast Cancer. 2007 Jun;7(8):608-18.PMID: 17592673 [PubMed - indexed for MEDLINE]Related articles

Valsartan versus lisinopril or extended-release metoprolol in preventing cardiovascular and renal events in patients with hypertension.

Delea TE, Taneja C, Moynahan A, Thomas SK, Frech-Tamas F, Oster G.

Am J Health Syst Pharm. 2007 Jun 1;64(11):1187-96.PMID: 17519461 [PubMed - indexed for MEDLINE]Related articles

Administrative claims analysis of utilization and costs of care in health plan members with atopic dermatitis who had prior use of a topical corticosteroid and who initiate therapy with pimecrolimus or tacrolimus.

Delea TE, Gokhale M, Makin C, Hussein MA, Vanderpoel J, Sandman T, Chang J, Sung J, Pinkston P, Gause D, Jackson M.

J Manag Care Pharm. 2007 May;13(4):349-59.PMID: 17506601 [PubMed - indexed for MEDLINE]Related articlesFree article

Impact of skeletal complications on total medical care costs among patients with bone metastases of lung cancer.

Delea TE, McKiernan J, Brandman J, Edelsberg J, Sung J, Raut M, Oster G.

J Thorac Oncol. 2006 Jul;1(6):571-6.PMID: 17409919 [PubMed - indexed for MEDLINE]Related articles

Cost effectiveness of once-daily oral chelation therapy with deferasirox versus infusional deferoxamine in transfusion-dependent thalassaemia patients: US healthcare system perspective.

Delea TE, Sofrygin O, Thomas SK, Baladi JF, Phatak PD, Coates TD.

Pharmacoeconomics. 2007;25(4):329-42.PMID: 17402805 [PubMed - indexed for MEDLINE]Related articles

Conclusions regarding relative cost-utility of alternative strategies for use of aromatase inhibitors in postmenopausal women with early breast cancer are premature.

Delea TE, Karnon J, Goss PE.

Ann Oncol. 2007 Jan;18(1):197-8; author reply 198-9. Epub 2006 Jul 27. No abstract available. PMID: 16873429 [PubMed - indexed for MEDLINE]Related articlesFree article

Cost-effectiveness of extended adjuvant letrozole therapy after 5 years of adjuvant tamoxifen therapy in postmenopausal women with early-stage breast cancer.

Delea TE, Karnon J, Smith RE, Johnston SR, Brandman J, Sung JC, Gross PE.

Am J Manag Care. 2006 Jul;12(7):374-86.PMID: 16834524 [PubMed - indexed for MEDLINE]Related articlesFree article

Use of surrogate measures in cost-effectiveness analyses of lipid-lowering therapies.

Delea TE.

Value Health. 1998 Sep;1(3):175-80.PMID: 16674349 [PubMed]Related articles

Treatment of peripheral neuropathic pain: a simulation model.

Vera-Llonch M, Dukes E, Delea TE, Wang ST, Oster G; Neuropathic Pain Outcomes Modeling Working Group.

Eur J Pain. 2006 Apr;10(3):279-85. Epub 2005 Jun 23.PMID: 15979360 [PubMed - indexed for MEDLINE]Related articles

Cost-effectiveness of fluvastatin following successful first percutaneous coronary intervention.

Delea TE, Jacobson TA, Serruys PW, Edelsberg JS, Oster G.

Ann Pharmacother. 2005 Apr;39(4):610-6. Epub 2005 Mar 1.PMID: 15741421 [PubMed - indexed for MEDLINE]Related articles

Death and hospitalization in heart failure patients receiving carvedilol vs. metoprolol tartrate.

Delea TE, Stanford R, Hagiwara M, Edelsberg JS, Oster G.

Int J Cardiol. 2005 Mar 10;99(1):117-24.PMID: 15721509 [PubMed - indexed for MEDLINE]Related articles

Outcomes and costs of risperidone versus olanzapine in patients with chronic schizophrenia or schizoaffective disorders: a Markov model.

Vera-Llonch M, Delea TE, Richardson E, Rupnow M, Grogg A, Oster G.

Value Health. 2004 Sep-Oct;7(5):569-84.PMID: 15367252 [PubMed - indexed for MEDLINE]Related articles

Therapy switching in patients receiving long-acting opioids.

Berger A, Hoffman DL, Goodman S, Delea TE, Seifeldin R, Oster G.

Ann Pharmacother. 2004 Mar;38(3):389-95. Epub 2004 Jan 12.PMID: 14742831 [PubMed - indexed for MEDLINE]Related articles

Use of thiazolidinediones and risk of heart failure in people with type 2 diabetes: a retrospective cohort study.

Delea TE, Edelsberg JS, Hagiwara M, Oster G, Phillips LS.

Diabetes Care. 2003 Nov;26(11):2983-9.PMID: 14578227 [PubMed - indexed for MEDLINE]Related articlesFree article

The incidence and cost of hospitalization for 5-FU toxicity among Medicare beneficiaries with metastatic colorectal cancer.

Delea TE, Vera-Llonch M, Edelsberg JS, McGarry L, Anton S, Ulcickas-Yood M, Oster G.

Value Health. 2002 Jan-Feb;5(1):35-43.PMID: 11873382 [PubMed - indexed for MEDLINE]Related articles

Use of oral antithrombotic agents among health maintenance organization members with atherosclerotic cardiovascular disease.

Brown JB, Delea TE, Nichols GA, Edelsberg J, Elmer PJ, Oster G.

Arch Intern Med. 2002 Jan 28;162(2):193-9.PMID: 11802753 [PubMed - indexed for MEDLINE]Related articlesFree article

Cost effectiveness of carvedilol for heart failure.

Delea TE, Vera-Llonch M, Richner RE, Fowler MB, Oster G.

Am J Cardiol. 1999 Mar 15;83(6):890-6.PMID: 10190405 [PubMed - indexed for MEDLINE]Related articles

The causal role for genital ulcer disease as a risk factor for transmission of human immunodeficiency virus. An application of the Bradford Hill criteria.

Dickerson MC, Johnston J, Delea TE, White A, Andrews E.

Sex Transm Dis. 1996 Sep-Oct;23(5):429-40. Review.PMID: 8885077 [PubMed - indexed for MEDLINE]Related articles

The benefits and risks of over-the-counter availability of nicotine polacrilex ("nicotine gum").

Oster G, Delea TE, Huse DM, Regan MM, Colditz GA.

Med Care. 1996 May;34(5):389-402.PMID: 8614162 [PubMed - indexed for MEDLINE]Related articles

The risks and benefits of an Rx-to-OTC switch. The case of over-the-counter H2-blockers.

Oster G, Huse DM, Delea TE, Colditz GA, Richter JM.

Med Care. 1990 Sep;28(9):834-52.PMID: 1976142 [PubMed - indexed for MEDLINE]Related articles

Cimetidine and adverse reactions: a meta-analysis of randomized clinical trials of short-term therapy.

Richter JM, Colditz GA, Huse DM, Delea TE, Oster G.

Am J Med. 1989 Sep;87(3):278-84.PMID: 2773966 [PubMed - indexed for MEDLINE]Related articles

Maternal smoking during pregnancy and expenditures on neonatal health care.

Oster G, Delea TE, Colditz GA.

Am J Prev Med. 1988 Jul-Aug;4(4):216-9.PMID: 3139017 [PubMed - indexed for MEDLINE]Related articles

Comment: cost-effectiveness methodology.

Oster G, Delea TE.

Drug Intell Clin Pharm. 1988 May;22(5):428-9. No abstract available. PMID: 3134185 [PubMed - indexed for MEDLINE]Related articles

Cost effectiveness of labetalol and propranolol in the treatment of hypertension among blacks.

Oster G, Huse DM, Delea TE, Savage DD, Colditz GA.

J Natl Med Assoc. 1987 Oct;79(10):1049-55. Review. No abstract available. PMID: 3119865 [PubMed - indexed for MEDLINE]Related articlesFree article

Nicotine chewing-gum.

Colditz GA, Huse DM, Delea TE, Oster G.

Lancet. 1987 Aug 22;2(8556):458. No abstract available. PMID: 2887763 [PubMed - indexed for MEDLINE]Related articles

Cost-effectiveness of nicotine gum as an adjunct to physician's advice against cigarette smoking.

Oster G, Huse DM, Delea TE, Colditz GA.

JAMA. 1986 Sep 12;256(10):1315-8.PMID: 3091857 [PubMed - indexed for MEDLINE]Related articles